Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Devroe Eric. Insider active across 1 company, notably Acrivon Therapeutics, Inc.. Aggregated, 14 reports have been logged. Split: 1 buy · 0 sell. Total volume traded: €15k. History available since 14 November 2022. The latest transaction was disclosed on 14 February 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Devroe Eric
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Devroe Eric is Chief Operating Officer at Acrivon Therapeutics, Inc. (XNAS). He has 14 filings in total, and across the recent filings tracked, buys amount to EUR 14758 and sells to EUR 0, over the period from 2022-11-16 to 2026-02-18, with Retenue fiscale as the most frequent transaction nature.